Connect with us

Tampa pharma firm elects new chair

April 15, 2019 - HedgePath Pharmaceuticals elected W. Mark Watson as chairman of the board, effective April 15. Watson, who is been on the HedgePath (OTC: HPPI) board since 2014, is a CPA who also serves on the board of Sykes Enterprises (Nasdaq: SYKE). E. Brendan Magrab, who has been HedgePath chair, is stepping down from that position in order to fulfill his duties as CEO of Epalex Corp., a news release said.

More Zaps Frontpage

The St. Pete Catalyst

The Catalyst honors its name by aggregating & curating the sparks that propel the St Pete engine.  It is a modern news platform, powered by community sourced content and augmented with directed coverage.  Bring your news, your perspective and your spark to the St Pete Catalyst and take your seat at the table.

Email us:

Subscribe for Free

Share with friend

Enter the details of the person you want to share this article with.